Clearbridge Investments LLC acquired a new stake in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 1,420,208 shares of the company's stock, valued at approximately $19,088,000. Clearbridge Investments LLC owned approximately 0.57% of Oscar Health as of its most recent filing with the SEC.
A number of other hedge funds also recently made changes to their positions in OSCR. KBC Group NV raised its position in Oscar Health by 56.1% during the fourth quarter. KBC Group NV now owns 7,107 shares of the company's stock valued at $96,000 after purchasing an additional 2,555 shares in the last quarter. ORG Wealth Partners LLC bought a new position in shares of Oscar Health during the 4th quarter valued at about $100,000. Alberta Investment Management Corp purchased a new position in shares of Oscar Health during the 4th quarter valued at about $138,000. Virtu Financial LLC bought a new stake in Oscar Health in the 4th quarter worth approximately $140,000. Finally, Potentia Wealth bought a new stake in Oscar Health in the 4th quarter worth approximately $141,000. 75.70% of the stock is owned by institutional investors.
Oscar Health Trading Down 3.8 %
NYSE:OSCR traded down $0.50 during midday trading on Monday, reaching $12.51. 5,628,562 shares of the stock traded hands, compared to its average volume of 3,810,658. The stock has a market capitalization of $3.13 billion, a P/E ratio of -624.94 and a beta of 1.75. Oscar Health, Inc. has a 12 month low of $11.89 and a 12 month high of $23.79. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The company has a fifty day moving average of $14.53 and a 200 day moving average of $15.68.
Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. On average, research analysts predict that Oscar Health, Inc. will post 0.69 EPS for the current year.
Analysts Set New Price Targets
Several research analysts have commented on OSCR shares. Jefferies Financial Group assumed coverage on shares of Oscar Health in a research note on Tuesday, December 10th. They set an "underperform" rating and a $12.00 price target on the stock. Wells Fargo & Company cut shares of Oscar Health from an "overweight" rating to an "equal weight" rating and decreased their target price for the stock from $20.00 to $16.00 in a research report on Thursday, March 13th. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating, two have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $20.21.
View Our Latest Research Report on Oscar Health
Oscar Health Company Profile
(
Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
See Also
Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Like this article? Share it with a colleague.
Link copied to clipboard.
